gonadotropin-releasing hormone

Preferred Label : gonadotropin-releasing hormone;

MeSH definition : A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.;

MeSH synonym : fsh-releasing hormone; lh-fsh releasing hormone; lhfshrh; gonadorelin; gnrh; lhfsh releasing hormone; lh-rh; releasing hormone, lhfsh; lhrh; luliberin; luteinizing hormone-releasing hormone; luteinizing hormone releasing hormone; gn-rh; fsh releasing hormone; gonadoliberin; lfrh; lh fsh releasing hormone; lh-releasing hormone; lh releasing hormone; gonadotropin releasing hormone;

CISMeF synonym : 5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig); lh/fsh-rh;

MeSH hyponym : gonadorelin acetate; kryptocur; cystorelin; factrel; dirigestran; gonadorelin hydrochloride;

MeSH CAS label : 5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig);

MeSH Related Number : gonadorelin acetate; gonadorelin hydrochloride; 51952-41-1 (Hydrochloride); 52699-48-6 (Acetate);

Registry Number MeSH : 33515-09-2;

Related CAS MeSH : 52699-48-6 (Gonadorelin acetate); 51952-41-1 (Gonadorelin hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Gonadotropin-releasing hormone;

Codes EINECS : 251-553-1;

Is substance : O;

Details

Origin ID

D007987;

UMLS CUI

C0023610;

ATC code(s)
- anti-gonadotropin-releasing hormones [ATC Code]
- gonadorelin [ATC Code]
- gonadorelin [ATC Code]
- gonadotropin releasing hormone analogues [ATC Code]
- gonadotropin-releasing hormones [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- gonadorelin [Substance BNPC]
Currated CISMeF NLP mapping
- Gonadorelin [ICD-11 Extension code]
- Gonadorelin (substance) [SNOMED CT concept]
- Gonadotrophin Releasing Hormone [NCIt concept]
- Gonadotropin releasing factor (substance) [SNOMED CT concept]
- Gonadotropin releasing hormone [LOINC component]
- Gonadotropin releasing hormone [LOINC Challenge]
- Luteotropin-releasing factor [FMA entity]
- Product containing gonadorelin (medicinal product) [SNOMED CT concept]
- gonadorelin [ATC Code]
- gonadotropin releasing factor [SNOMED Notion]
- gonadotropin-releasing hormones [ATC Code]
- luteinizing hormone releasing factor [SNOMED Notion]
Indexing information
- 11-deoxy-11-(carboxy(3,4-dichlorophenethyl)amino)-3-O-(4-methyloxazolidin-2-one-3-yl)carbamoyl-5-O-(3'-N-desmethyl-3'-N-cyclopropylmethyl)desosaminyl-6-O-methylerythronolide A 11,12-(cyclic carbamate) [MeSH Supplementary Concept]
- 2-naphthylalanyl-glutamic acid [MeSH Supplementary Concept]
- 5-((3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-N-(2,4,6-trimethoxyphenyl)-2-furamide [MeSH Supplementary Concept]
- GNRH precursor (14-26) [MeSH Supplementary Concept]
- GnRH, Ac(3,4)-dehydro-Pro(1)-4-fluoro-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, His(5)-Tyr(6)- [MeSH Supplementary Concept]
- LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- [MeSH Supplementary Concept]
- N-acetyl-3-(3-quinolyl)alanyl-3-(4-chlorophenyl)alanyl-3-(3-pyridyl)alanyl-seryl-3-(4-pyrazinylcarbonylaminocyclohexyl)alanyl-N(epsilon)picolinoyllysyl-valyl-arginyl-prolyl-alaninamide [MeSH Supplementary Concept]
- acetyl-(2-naphthyl)alanyl-4-chlorophenylalanyl-3-(3-pyridinyl)alanyl-seryl-histidyl-n5-aminocarbonylornithyl-tryptophyl-tyrosyl-prolyl-alaninamide [MeSH Supplementary Concept]
- acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide [MeSH Supplementary Concept]
- acetyl-2-naphthylalanyl-chlorophenylalanyl-1-oxohexadecyl-glycyl-arginyl-prolyl-alaninamide [MeSH Supplementary Concept]
- acetyl-tryptophyl-leucyl-aspartyl-isoleucyl-isoleucyl-tryptophan [MeSH Supplementary Concept]
- acyline [MeSH Supplementary Concept]
- azaglycylnafarelin [MeSH Supplementary Concept]
- cyclo(acetyl-isoleucyl-isoleucyl-tryptophyl-tryptophyl-leucyl-cysteinyl) [MeSH Supplementary Concept]
- ganirelix [MeSH Supplementary Concept]
- gonadorelin-like peptides [MeSH Supplementary Concept]
- iodothyronine deiodinase type II [MeSH Supplementary Concept]
- orntide acetate [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-tryptophyl-seryl-tyrosyl-alanyl-leucyl-arginyl-prolyl-glycinamide [MeSH Supplementary Concept]
Record concept(s)
- Gonadotropin-Releasing hormone [MeSH concept]
- cystorelin [MeSH concept]
- dirigestran [MeSH concept]
- factrel [MeSH concept]
- gonadorelin acetate [MeSH concept]
- gonadorelin hydrochloride [MeSH concept]
- kryptocur [MeSH concept]
Related MeSH Supplementary Concept(s)
- (beta-Asp(alpha-DEA))(6),Gln(8)-GnRH [MeSH Supplementary Concept]
- (des-Gly10,D-Ala6)-LHRH ethylamide [MeSH Supplementary Concept]
- (lysine(6)(1,3,8-trihydroxy-6-carboxyanthraquinone))GnRH [MeSH Supplementary Concept]
- 5-oxo-pro-his-trp-ser-tyr-gly-trp-leu-pro-glynh2 [MeSH Supplementary Concept]
- 9-hydroxyproline-gonadorelin [MeSH Supplementary Concept]
- A 76154 [MeSH Supplementary Concept]
- AEZS-125 [MeSH Supplementary Concept]
- AN 207 [MeSH Supplementary Concept]
- Arhgap39 protein, rat [MeSH Supplementary Concept]
- BIM 21009 [MeSH Supplementary Concept]
- GnRH (1-9)nonapeptide ethylamide, penicillamine-(tert-butyl)(6)- [MeSH Supplementary Concept]
- GnRH, (Ac-dehydro-Pro(1)-4-Cl-Phe(2)-Trp(3,6))-N-(alpha)-MeLeu(7)- [MeSH Supplementary Concept]
- GnRH, Ac(3,4)-dehydro-Pro(1)-4-fluoro-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- GnRH, Ac(4-Cl-Phe(1,2)-Trp(3)-Tyr(5)-Lys(6)-Ala(10))- [MeSH Supplementary Concept]
- GnRH, Trp(6)-N-Me-Leu(7)-Pro(9)-N-Et- [MeSH Supplementary Concept]
- GnRH, acetyl(4-azidobenzoyl)-Lys(1)-4-chloro-Phe(2),Trp(3),Arg(6),Ala(10)- [MeSH Supplementary Concept]
- GnRH-II, Ac-2-Nal(1)-4Cpa(2)-3Pal(3,6)-Leu(8)-Ala(10)- [MeSH Supplementary Concept]
- GnRH-II, Lys(6)- [MeSH Supplementary Concept]
- GnRH-III, acetyllysyl(4)-(daunorubicin-aminooxyacetyl)lysyl(8)- [MeSH Supplementary Concept]
- GnRH-hinge-MVP peptide [MeSH Supplementary Concept]
- GnRH3-hinge-MVP [MeSH Supplementary Concept]
- L-GnRH-PE66 protein, chimeric [MeSH Supplementary Concept]
- LHRH (1-10) [MeSH Supplementary Concept]
- LHRH (1-5) [MeSH Supplementary Concept]
- LHRH (1-6) [MeSH Supplementary Concept]
- LHRH (1-6), GlyNH2(6)- [MeSH Supplementary Concept]
- LHRH (1-9) [MeSH Supplementary Concept]
- LHRH (2-10) [MeSH Supplementary Concept]
- LHRH (2-10), Trp(6)- [MeSH Supplementary Concept]
- LHRH cysteamide, des-Arg- [MeSH Supplementary Concept]
- LHRH ethylamide, des-Gly(10)-Ala(6)- [MeSH Supplementary Concept]
- LHRH propylamide, Ala(6)-des-Gly(10)- [MeSH Supplementary Concept]
- LHRH(5-10), ac- [MeSH Supplementary Concept]
- LHRH, (1,9)-nonapeptide N-Et-ProNH(2)(9)-Gln(cyclohexyl)(6)-des-GlyNH(2)(10)- [MeSH Supplementary Concept]
- LHRH, (3-(1H-pyrazol-3-yl))-Ala(2)- [MeSH Supplementary Concept]
- LHRH, (N)-Ac-3(2-naphthyl)Ala(1)-(4-Cl-Phe)(2)-Trp(3)-Arg(6)-Phe(7)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, 1,6-cyclo(Ac-Glu(1)-Phe(2)-Trp(3)-Lys(6))- [MeSH Supplementary Concept]
- LHRH, 4-ClPhe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, 4-amino-Phe(6)- [MeSH Supplementary Concept]
- LHRH, Ac-(4-Cl-Phe(1,2)-Trp(3)-Lys(6)-Ala(10))- [MeSH Supplementary Concept]
- LHRH, Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-4-methoxybenzoyl-2-ABA(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, Ac-2-Nal(1)-4-Cl-Phe(2)-Trp(3)-Arg(Et2)(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, Ac-2-Nal(1)-4-Cl-Phe(2)-Trp(3)-Ser(Rha)(6)-AzGlyNH2(10)- [MeSH Supplementary Concept]
- LHRH, Ac-Nal(1)-4-Cl-Phe(2)-Pal(3,6)- [MeSH Supplementary Concept]
- LHRH, Ac-Nal(1)-4-Cl-Phe(2)-Trp(3)-Arg(6)-Trp(7)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, Ac-Nal(1)-Cpa(2)-Pal(3,6)-Arg(5)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, Ac-Nal-Ala(1)-4-Cl-Phe(2)-Ser(Rha)(6)- [MeSH Supplementary Concept]
- LHRH, Ac-dehydro-Phe(1)-dehydro-4-Cl-Phe(2)-dehydro-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, Ac-dehydro-Pro(1)-4-Cl-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, Ac-dehydro-Pro(1)-4-F-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, Ac-delta(3)-Pro(1)-4-F-Phe(2)-Trp(3)-Lys(6)- [MeSH Supplementary Concept]
- LHRH, Ala(6)- [MeSH Supplementary Concept]
- LHRH, Ala(6)-Gly(10)-ethylamide- [MeSH Supplementary Concept]
- LHRH, Ala(6)-N-Et-ProNH2(9)-iodo- [MeSH Supplementary Concept]
- LHRH, Ala(6)-des-Gly(10)- [MeSH Supplementary Concept]
- LHRH, Boc-(Bzl)Ser(1)-des-His(2)-Trp(6)- [MeSH Supplementary Concept]
- LHRH, Gln(1)-des-His(2)-Phe(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, Gln(8)- [MeSH Supplementary Concept]
- LHRH, Gly(10)- [MeSH Supplementary Concept]
- LHRH, His(5)-Arg(6)-Trp(7)-Tyr(8)- [MeSH Supplementary Concept]
- LHRH, His(5)-Trp(7)-Tyr(8)- [MeSH Supplementary Concept]
- LHRH, His(5)-Tyr(6)- [MeSH Supplementary Concept]
- LHRH, His(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, Leu(6)- [MeSH Supplementary Concept]
- LHRH, Leu(6)-Leu(N-alpha-Me)(7)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, Leu(6)-N-Et-GlyNH2(10)- [MeSH Supplementary Concept]
- LHRH, Leu(6)-des-Et-GlyNH2(10)- [MeSH Supplementary Concept]
- LHRH, Lys(6)- [MeSH Supplementary Concept]
- LHRH, Lys(6)-EGS-Lys(6)-LHRH [MeSH Supplementary Concept]
- LHRH, Lys(6)-N-Et-GlyNH2(10)- [MeSH Supplementary Concept]
- LHRH, Lys(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, Lys(8)- [MeSH Supplementary Concept]
- LHRH, N-(Ac)-Trp(1)-(4-Cl-Phe)(2)-Trp(3)-Trp(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac(2)-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-5-(4-methoxyphenyl)-5-oxo-2-aminopentanoic acid(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-(4-Cl-Phe)(1,2)-Phe(3)-Arg(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-(4-Cl-Phe)(1,2)-Trp(3)-Arg(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-(4-F-Phe)(1)-(4-Cl-Phe)(2)-Trp(3,6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-Trp(3)-Hci(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-2-naphthyl-Ala(1)-4-chloro-Phe(2)-pyridyl-Ala(3)-nicotinyl-Lys(5,6)-isopropyl-Lys(8)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-3(2-naphthyl)Ala(1)-Phe(2,3)-Arg(6)-Phe(7)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-3-(2-dibenzofuranyl)-Ala(1)- [MeSH Supplementary Concept]
- LHRH, N-Ac-Ala(1)-(4-Cl-Phe)(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, N-Ac-Gly(1)-(4-Cl-Phe)(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, N-Ac-Nal(1)-4-Cl-Phe(2)-Trp(3)-Cit(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-O-phenylTyr(1)- [MeSH Supplementary Concept]
- LHRH, N-Ac-Pro(1)-(4-Cl-Phe)(2)-(2-naphthyl-Ala)(3,6)- [MeSH Supplementary Concept]
- LHRH, N-Ac-Trp(1)-(4-Cl-Phe)(2)-Trp(3)-Arg(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, N-Ac-muramyl-Ala-iso-Glu-LysNH2- [MeSH Supplementary Concept]
- LHRH, N-Ac-naphthyl(1)-(4-Cl-Phe)(2)-Trp(3)-Arg(6)-Ala(10)- [MeSH Supplementary Concept]
- LHRH, N-Et-AlaNH2(6)- [MeSH Supplementary Concept]
- LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- [MeSH Supplementary Concept]
- LHRH, N-epsilon-azidobenzoyl-Lys(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-Ala(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-Leu(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-N-epsilon-(2,4)-dinitrophenol-Lys(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-Pro(3)-Phe(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-Trp(3)-Phe(6)- [MeSH Supplementary Concept]
- LHRH, Phe(2)-Trp(6)- [MeSH Supplementary Concept]
- LHRH, Phe(5)-delta-Ala(6)- [MeSH Supplementary Concept]
- LHRH, Phe(5)-delta-Ala(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, Phe(6)- [MeSH Supplementary Concept]
- LHRH, Phe(7)- [MeSH Supplementary Concept]
- LHRH, Pro(1)-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, Ser(6)- [MeSH Supplementary Concept]
- LHRH, Trp(6)-des-GlyNH2(10)- [MeSH Supplementary Concept]
- LHRH, Trp(7)- [MeSH Supplementary Concept]
- LHRH, Trp(8)- [MeSH Supplementary Concept]
- LHRH, acetyl-2-(2-naphthyl)-Ala(1)-4-F-Phe(2)-Trp(3)-Arg(6)- [MeSH Supplementary Concept]
- LHRH, biotin-Lys(6)- [MeSH Supplementary Concept]
- LHRH, cLeu(7)- [MeSH Supplementary Concept]
- LHRH, cyclohexyl-Ala(7)- [MeSH Supplementary Concept]
- LHRH, des-His(2)-Ala(6)- [MeSH Supplementary Concept]
- LHRH, des-His(2)-Ala(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, des-His(2)-Leu(6)- [MeSH Supplementary Concept]
- LHRH, des-Tyr(5)- [MeSH Supplementary Concept]
- LHRH, hydroxyprolyl(9)- [MeSH Supplementary Concept]
- LHRH, lysine(6)-doxorubicin [MeSH Supplementary Concept]
- LHRH, lysine(6)-glutaryl-2-(hydroxymethyl)anthraquinone [MeSH Supplementary Concept]
- LHRH, pGlu(1)-4-Cl-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3)-Lys(6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3)-Ser(4)-N-epsilon-azidobenzoyl-Lys(6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, rhodamine [MeSH Supplementary Concept]
- LHRH, rhodamine-Lys(6)- [MeSH Supplementary Concept]
- LHRH,(N)-Ac-(4-Cl-Phe)(1)-(4-Cl-Phe)(2)-Trp(3)-Phe(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- LHRH,(N)-Ac-Trp(1)-(4-Cl-Phe)(2)-Trp(3)-Phe(6)-AlaNH2(10)- [MeSH Supplementary Concept]
- MI 1544 [MeSH Supplementary Concept]
- MI 1892 [MeSH Supplementary Concept]
- MP 264 [MeSH Supplementary Concept]
- MP 265 [MeSH Supplementary Concept]
- N-Ac-(4-Cl-Phe)(1)-(4-Cl-Phe)(2)-Trp(3)-Lys(6)-AlaNH2(10)-LHRH [MeSH Supplementary Concept]
- N-acetyl-3-(3-quinolyl)alanyl-3-(4-chlorophenyl)alanyl-3-(3-pyridyl)alanyl-seryl-3-(4-pyrazinylcarbonylaminocyclohexyl)alanyl-N(epsilon)picolinoyllysyl-valyl-arginyl-prolyl-alaninamide [MeSH Supplementary Concept]
- P-X 1544 [MeSH Supplementary Concept]
- P-X 1892 [MeSH Supplementary Concept]
- RS 15378 [MeSH Supplementary Concept]
- RS 18286 [MeSH Supplementary Concept]
- alarelin [MeSH Supplementary Concept]
- argtide [MeSH Supplementary Concept]
- azaline [MeSH Supplementary Concept]
- azo-GnRH tetanus toxoid conjugate [MeSH Supplementary Concept]
- azo-LHRH-bovine serum albumin conjugate [MeSH Supplementary Concept]
- azo-LHRH-tetanus toxoid conjugate [MeSH Supplementary Concept]
- bovine serum albumin-LHRH conjugate [MeSH Supplementary Concept]
- cerebellar ataxia and hypogonadotropic hypogonadism [MeSH Supplementary Concept]
- cetrorelix [MeSH Supplementary Concept]
- cyclo(4-9)GnRH, Lys(4)-Trp(6)-Glu(9)- [MeSH Supplementary Concept]
- dalarelin [MeSH Supplementary Concept]
- detirelix [MeSH Supplementary Concept]
- fertirelin [MeSH Supplementary Concept]
- folligen [MeSH Supplementary Concept]
- ganirelix [MeSH Supplementary Concept]
- gonadorelin(6-D-Phe) [MeSH Supplementary Concept]
- gonadorelin-like peptides [MeSH Supplementary Concept]
- gonadotropin releasing hormone associated peptide [MeSH Supplementary Concept]
- gonadotropin-releasing hormone-III [MeSH Supplementary Concept]
- histrelin [MeSH Supplementary Concept]
- lamprey GnRH-I [MeSH Supplementary Concept]
- lutrelin acetate [MeSH Supplementary Concept]
- meterelin [MeSH Supplementary Concept]
- nymfon-orion [MeSH Supplementary Concept]
- org 30850 [MeSH Supplementary Concept]
- orntide acetate [MeSH Supplementary Concept]
- ovaprim [MeSH Supplementary Concept]
- ovurelin [MeSH Supplementary Concept]
- phLHRH (14-36), Ala(17)- [MeSH Supplementary Concept]
- pro-LHRH (14-69)OH [MeSH Supplementary Concept]
- progonadoliberin I [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-tryptophyl--seryl-tyrosyl-tryptophyl-leucyl-arginyl-prolyl-glycinamide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-tryptophyl-seryl-tyrosyl methyl ester [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-tryptophyl-seryl-tyrosyl-alanyl-leucyl-arginyl-N-ethylprolinamide [MeSH Supplementary Concept]
- relisorm L [MeSH Supplementary Concept]
- ricin A-GnRH conjugate [MeSH Supplementary Concept]
- salmon gonadotropin-releasing hormone precursor [MeSH Supplementary Concept]
- surfagon [MeSH Supplementary Concept]
- vaxstrate [MeSH Supplementary Concept]
- wy 40905 [MeSH Supplementary Concept]
- wy 43657 [MeSH Supplementary Concept]
See also
- kallmann syndrome [MeSH Descriptor]
- receptors, LHRH [MeSH Descriptor]
See also inter- (CISMeF)
- Gonadorelin Acetate [NCIt concept]
- Gonadorelin acetate (substance) [SNOMED CT concept]
- Recombinant Gonadorelin [NCIt concept]
- gonadorelin acetate [SNOMED Notion]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Gonadorelin (substance) [SNOMED CT concept]
- Gonadotrophin Releasing Hormone [NCIt concept]
- Gonadotropin releasing factor (substance) [SNOMED CT concept]
- Gonadotropin releasing hormone [LOINC component]
- Gonadotropin releasing hormone [LOINC Challenge]
- Luteotropin-releasing factor [FMA entity]
- Product containing gonadorelin (medicinal product) [SNOMED CT concept]
- Product containing gonadotropin releasing factor (product) [SNOMED CT concept]
- follicle stimulating hormone releasing factor preparation [SNOMED Notion]
- gonadorelin [ATC Code]
- gonadorelin [ATC Code]
- gonadorelin [Substance BNPC]
- gonadotropin releasing factor [SNOMED Notion]
- gonadotropin releasing factor preparation [SNOMED Notion]
- gonadotropin-releasing hormones [ATC Code]
- luteinizing hormone releasing factor [SNOMED Notion]
- luteinizing hormone releasing factor preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- gonadorelin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients